Introduction
In a landmark development for international public health governance, the World Health Organization (WHO) and the Swiss Confederation have officially renewed their Country Cooperation Strategy (CCS) for the 2024–2028 period. This formal agreement, signed on March 4, 2025, at the WHO Regional Office for Europe in Copenhagen, Denmark, reaffirms a long-standing partnership between a leading global health agency and its host nation. By formalizing this roadmap, both entities aim to address the increasingly complex challenges of the post-pandemic era, ranging from pandemic preparedness and digital health innovation to the strengthening of global health architecture.
The Evolution of the Partnership: A Historical Chronology
The relationship between Switzerland and the WHO is unique, defined not only by geographical proximity—with the WHO’s headquarters situated in Geneva—but by a deeply integrated policy framework.
2013: Breaking New Ground
The genesis of this structured cooperation dates back to 2013, when Switzerland achieved a historic milestone by becoming the first high-income country within the WHO European Region to pilot a formal Country Cooperation Strategy. Prior to this, CCS frameworks were predominantly utilized for low- and middle-income nations to align WHO resources with national health priorities. By adopting this model, Switzerland signaled its commitment to evidence-based policy and multilateral cooperation, setting a precedent for other developed nations.
2022–2024: The Strategic Refresh
Following the global disruptions caused by COVID-19, the need for a more agile and responsive partnership became evident. In 2022, leadership from both the Swiss Federal Office of Public Health and the WHO began the consultative process to modernize the existing framework. This period involved rigorous evaluation of previous objectives, identifying successes in pandemic response and areas requiring increased investment, such as health system resilience and equitable access to medical countermeasures.
March 4, 2025: Formalizing the Future
The culmination of these efforts occurred in Copenhagen, where Dr. Hans Kluge, WHO Regional Director for Europe, and Barbara Schedler, Ambassador for Global Health at the Swiss Federal Office of Public Health, signed the 2024–2028 strategy. The document represents a shared vision for the next four years, moving beyond traditional advisory roles to a model of proactive, collaborative problem-solving.
Strategic Pillars: Core Objectives of the 2024–2028 Strategy
The new strategy is not merely a document of intent but a roadmap of specific, actionable priorities. It is built upon several foundational pillars that address the modern health landscape:
1. Strengthening Global Health Architecture
Switzerland plays a central role in the governance of international health. The partnership focuses on enhancing the resilience of the global health architecture, ensuring that international regulations are not only robust but also enforceable. This includes supporting the WHO in its efforts to create a "Pandemic Treaty" and ensuring that the lessons learned from the 2020–2022 crisis are translated into permanent, systemic improvements.
2. Digital Health and Innovation
As a global hub for technology and pharmaceuticals, Switzerland is uniquely positioned to lead in the digital health transition. The 2024–2028 strategy emphasizes the integration of artificial intelligence (AI) in public health surveillance, data interoperability across European borders, and the ethical management of health data.
3. Sustainability and BioHub Systems
The strategy explicitly links to the ongoing collaboration regarding the WHO BioHub system. This system, which facilitates the voluntary sharing of pathogens and biological materials for research and vaccine development, is a cornerstone of global biosecurity. Switzerland’s commitment to providing the necessary laboratory infrastructure and diplomatic support ensures that the BioHub remains a neutral, transparent, and highly efficient platform for global scientific progress.
Supporting Data and Collaborative Synergy
The effectiveness of the WHO-Switzerland partnership is supported by a history of high-level contributions. Switzerland consistently ranks among the top contributors to the WHO’s voluntary core budget, providing the agency with the flexibility required to respond to health emergencies.
- Resource Mobilization: Over the past decade, Swiss contributions have surged, particularly in support of the WHO’s Health Emergencies Programme.
- Scientific Expertise: The partnership leverages the expertise of Swiss research institutes and the University of Geneva, facilitating the transfer of academic findings into actionable WHO guidelines.
- Human Capital: Switzerland provides a significant proportion of the WHO’s technical staff, ensuring that the agency is staffed by world-class experts in epidemiology, health policy, and biostatistics.
Official Responses and Diplomatic Perspectives
The signing ceremony in Copenhagen was marked by an atmosphere of mutual reliance and optimism.
Dr. Hans Kluge, WHO Regional Director for Europe, emphasized that the renewal of the strategy is an acknowledgment of the changing geopolitical environment. "Switzerland is more than a host country; it is a vital partner in the shaping of health policy for the entire European Region," Dr. Kluge noted. "By aligning our strategies, we are ensuring that the lessons of the last decade are not forgotten but are instead codified into the systems we use to protect future generations."
Ambassador Barbara Schedler, representing the Swiss Federal Office of Public Health, highlighted the importance of multilateralism. "The challenges we face today—whether they are pandemic-related, climate-induced health crises, or the rise of non-communicable diseases—are too vast for any single nation to address alone. Our partnership with the WHO reflects Switzerland’s unwavering belief that global health security is synonymous with national health security."
Implications for the Future: A New Standard
The renewal of the CCS carries significant implications for the European region and the global community at large.
Implications for Global Health Security
By setting a high standard for how a high-income nation engages with the WHO, Switzerland is encouraging a "whole-of-society" approach to health. This model demonstrates that even the most advanced healthcare systems benefit from the standardization and oversight provided by the WHO.
Implications for Policy Coordination
The 2024–2028 strategy serves as a blueprint for policy harmonization. As Europe navigates the complexities of an aging population and increasing health disparities, the collaboration ensures that Switzerland’s internal policies remain consistent with the broader European Programme of Work (EPW), which promotes Universal Health Coverage (UHC) and mental health advocacy.
The Role of the "BioHub"
The ongoing work with the Global BioHub system remains one of the most practical applications of this partnership. By securing a reliable, transparent pipeline for biological data, the WHO and Switzerland are building a "defensive wall" against future pathogen outbreaks. This serves as a model for other nations to follow, proving that the sharing of biological data is a security asset rather than a liability.
Conclusion: A Vision Beyond 2028
As the world moves further into the 21st century, the boundaries between local health and global health are becoming increasingly blurred. The 2024–2028 WHO-Switzerland Cooperation Strategy is a recognition of this reality. It is a commitment to a future where health is treated as a global public good, protected by robust institutions and sustained by the collaboration of nations.
The agreement signed in March 2025 is not just a routine administrative renewal; it is a strategic maneuver designed to ensure that when the next health crisis inevitably arrives, the international community is prepared, coordinated, and equipped with the best possible data and infrastructure. Through this partnership, Switzerland and the WHO are signaling to the rest of the world that proactive cooperation is the only sustainable path forward in an increasingly volatile global landscape.
As implementation begins, the global health community will be watching closely, expecting that the outputs of this partnership—from enhanced digital surveillance to improved vaccine distribution logistics—will serve as the benchmark for international health cooperation for years to come.
About the Author
